Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology

Authoring Organizations

Publication Month/Year

May 22, 2024

Last Updated Month/Year

June 17, 2024

Supplemental Implementation Tools

Document Type


Country of Publication


Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Infant, Older adult

Health Care Settings

Ambulatory, Home health, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, community pharmacist, health systems pharmacist, pharmacy technician, physician, physician assistant


Treatment, Management, Prevention

Diseases/Conditions (MeSH)

D002173 - Cancer Care Facilities, D000903 - Antibiotics, Antineoplastic, D000964 - Antimetabolites, Antineoplastic, D000970 - Antineoplastic Agents, D018906 - Antineoplastic Agents, Alkylating, D000074322 - Antineoplastic Agents, Immunological, D000972 - Antineoplastic Agents, Phytogenic, D000971 - Antineoplastic Combined Chemotherapy Protocols, D024221 - Antineoplastic Protocols


antineoplastic agents, standards, antineoplastic therapy

Source Citation

Siegel RD, LeFebvre KB, Temin S, et al. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. JCO Oncol Pract. 2024 May 22. doi: 10.1200/OP.24.00216.

Supplemental Methodology Resources

Evidence Tables


Number of Source Documents
Literature Search Start Date
January 1, 2015
Literature Search End Date
April 1, 2023